PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Mar 2008 (Vol:2008, Issue: 93)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Patent Reform Could Threaten Innovation Published: 5 Mar-2008
By: Fintan Walton
Abstract Fulltext:
Section: Cartoons
Patent Published: 8 Mar-2008
Details
Section: Company Profile
Novo Nordisk AS Published: 8 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Yondelis (Trabectedin) Published: 8 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Section: Features
Amgen Forced to Surrender Japan Published: 1 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Expanding Large Molecule Capabilities: Teva#8217;s Latest Acquisition Published: 1 Mar-2008
By: Business Review Editor
Abstract Fulltext:
The War Dividend Published: 1 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Therapy Focus #8211; Melanoma Vaccines Published: 1 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Section: General
Clinical Development Attrition Rates Published: 8 Mar-2008
By: John Janes
Abstract Fulltext:
Section: Licensing
Forest Licenses Novexel’s Novel Broad-Spectrum Beta-Lactamase Inhibitor Published: 8 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Nycomed Finds Commercialisation Partner for Ciclesonide Published: 8 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
GE Healthcare Acquires Whatman Published: 8 Mar-2008
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Acceleron Signs Deals for Bone-Forming Compounds Published: 8 Mar-2008
By: Business Review Editor
Abstract Fulltext:

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Table of Contents

Login

Bookmarks